Pulsenmore Ltd.
Pulsenmore Ltd. is a medical device company that develops portable self-scan ultrasound solutions for remote clinical diagnosis and screening. Its current product lineup includes home-use ultrasound systems that connect with a patient’s smartphone, allowing users to capture images for review by healthcare professionals. The company also provides a mobile application that guides patients through the scanning process and supports online consultation, along with a clinician dashboard for remote image review and scan supervision. Pulsenmore Ltd. focuses on applications in telehealth and remote monitoring, with solutions used in maternal health and fertility care. Headquartered in Omer, Israel, Pulsenmore Ltd. serves healthcare providers and patients seeking convenient ultrasound access outside traditional clinical settings.
$1.87
+$0.06 (+3.31%)
EOD Oct 16, 2026
The business is unprofitable at the operating level (-30.39% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 314.3% YoY with margins expanding 406.6pp.
Negative free cash flow of -ILS 33M. The business is consuming cash, not generating it.
Price History
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
ILS 40M
▲ +314.3% YoY
Net Income (TTM)
-ILS 16M
▲ +56.8% YoY
Op. Margin
-30.39%
▲ +406.6pp YoY
ROIC
-10.46%
▲ +18.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-ILS 33M
▲ +21.3% YoY
Op. Cash Flow (TTM)
-ILS 33M
▲ +20.7% YoY
Net Debt
-ILS 68M
Net Cash Position
Cash & Equiv.
ILS 69M
3Y CAGR: +54.7%
Continue Research
Is Pulsenmore (PLSM) overvalued?
Pulsenmore (PLSM)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Pulsenmore scores 40/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from company filings; read the full methodology, or see how the market compares in our US profitability statistics. This is analysis, not investment advice.
Frequently asked
Is Pulsenmore a high-quality business?+
Pulsenmore scores 40 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a -30.4% operating margin and a -10.5% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from company filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Is Pulsenmore a good stock to buy right now?+
That depends on valuation and quality together, not either alone. you should weigh PLSM's valuation and scores 40/100 on quality (mixed). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from company filings, not investment advice.
Related stocks: Medical Devices
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.